AR123345A1 - Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus - Google Patents

Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus

Info

Publication number
AR123345A1
AR123345A1 ARP210102396A ARP210102396A AR123345A1 AR 123345 A1 AR123345 A1 AR 123345A1 AR P210102396 A ARP210102396 A AR P210102396A AR P210102396 A ARP210102396 A AR P210102396A AR 123345 A1 AR123345 A1 AR 123345A1
Authority
AR
Argentina
Prior art keywords
disease
coronavirus infection
alleviate
coronavirus
prevent
Prior art date
Application number
ARP210102396A
Other languages
English (en)
Inventor
Se Chan Kang
Yong Joon Jeong
Hye Lin Jeon
Yang Mi Her
Original Assignee
Genencell Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencell Co Ltd filed Critical Genencell Co Ltd
Publication of AR123345A1 publication Critical patent/AR123345A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus, que contiene un extracto de hoja de Elaeocarpus sylvestris como un ingrediente activo, y una composición alimenticia para prevenir o aliviar infección por coronavirus. Debido a que el extracto de hoja de Elaeocarpus sylvestris exhibe excelente actividad anti viral contra el coronavirus que es un virus que causa una enfermedad respiratoria, una enfermedad digestiva, una enfermedad hepática o una enfermedad cerebral en un mamífero, particularmente, el coronavirus-19, puede utilizarse efectivamente en medicamentos y alimentos para prevenir, aliviar o tratar una enfermedad provocada por infección por coronavirus.
ARP210102396A 2020-09-07 2021-08-25 Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus AR123345A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200113730A KR102204299B1 (ko) 2020-09-07 2020-09-07 담팔수 추출물을 유효성분으로 포함하는 코로나 바이러스 치료제

Publications (1)

Publication Number Publication Date
AR123345A1 true AR123345A1 (es) 2022-11-23

Family

ID=74304832

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102396A AR123345A1 (es) 2020-09-07 2021-08-25 Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus

Country Status (11)

Country Link
US (1) US20220313764A1 (es)
EP (1) EP3991742A4 (es)
JP (1) JP2022551019A (es)
KR (1) KR102204299B1 (es)
CN (1) CN114502184A (es)
AR (1) AR123345A1 (es)
BR (1) BR112021017314A2 (es)
CA (1) CA3128310A1 (es)
MX (1) MX2021010213A (es)
TW (1) TWI787950B (es)
WO (1) WO2022050516A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022216107A1 (ko) * 2021-04-09 2022-10-13 주식회사 더퓨쳐 담팔수 추출물 또는 이의 정제물을 유효성분으로 함유하는 항암용 조성물
KR102538022B1 (ko) * 2021-04-12 2023-06-07 주식회사 더퓨쳐 담팔수 추출물 또는 이의 정제물을 유효성분으로 함유하는 항균용 조성물
KR20230028163A (ko) 2021-08-21 2023-02-28 주식회사 엑소코바이오 항바이러스 활성이 강화된 엑소좀의 생산방법 및 이의 응용
KR102408542B1 (ko) * 2021-11-29 2022-06-16 농업회사법인 휴림황칠(주) 반려동물용 항균 및 항코로나 바이러스 조성물, 및 그 제조방법
KR20230143964A (ko) 2022-04-06 2023-10-13 서울대학교산학협력단 바이러스 감염증의 예방 또는 치료용 약학 조성물
CN114796172A (zh) * 2022-05-26 2022-07-29 中国科学院昆明植物研究所 具有乙酰胆碱酯酶抑制活性的山杜英枝叶提取物活性部位和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100791108B1 (ko) * 2006-11-06 2008-01-03 제주대학교 산학협력단 방사선 방호효과를 갖는 담팔수 분획농축물과 그 제조방법
KR20100080972A (ko) * 2009-01-05 2010-07-14 김선일 나무수액 발효물과 그 이용방법.
KR20140024877A (ko) * 2011-03-28 2014-03-03 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형
KR101834872B1 (ko) * 2016-09-09 2018-04-13 주식회사 제넨셀 담팔수 추출물 또는 이의 분획물을 유효 성분으로 포함하는 알파 계열 허피스 바이러스 감염증의 예방 또는 치료용 약제학적 조성물
KR101874745B1 (ko) * 2017-04-19 2018-07-04 가천대학교 산학협력단 담팔수 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
KR20190121956A (ko) * 2018-04-19 2019-10-29 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물

Also Published As

Publication number Publication date
JP2022551019A (ja) 2022-12-07
MX2021010213A (es) 2022-04-12
CA3128310A1 (en) 2022-03-07
EP3991742A4 (en) 2023-02-01
WO2022050516A1 (ko) 2022-03-10
EP3991742A1 (en) 2022-05-04
CN114502184A (zh) 2022-05-13
TW202210088A (zh) 2022-03-16
US20220313764A1 (en) 2022-10-06
BR112021017314A2 (pt) 2023-03-14
TWI787950B (zh) 2022-12-21
KR102204299B1 (ko) 2021-01-20

Similar Documents

Publication Publication Date Title
AR123345A1 (es) Una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus
BR112018016001A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
AR122899A1 (es) Combinación de vacunas
BR112019008431A2 (pt) aplicação de (s)-norcetamina e sal da mesma como fármaco
BR112017016663A2 (pt) oligômero, conjugado, composição, kit, e, métodos para inibir ou reduzir a expressão de proteína tau em uma célula e para tratar ou prevenir um distúrbio neurológico
BR112015006055A2 (pt) composições e métodos para o tratamento e prevenção de lesão tecidual e doença
PH12015502230B1 (en) Novel viral replication inhibitors
ECSP20029558A (es) Nuevas indol-2-carboxamidas sustituidas con amino-tiazol, de alta actividad, activas contra el virus de la hepatitis b (vhb)
WO2013022846A3 (en) Flavonoid compounds
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
CL2020003225A1 (es) Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda (ahpnd, por su sigla en inglés) o el síndrome de las manchas blancas (wss, por su sigla en inglés), que comprende una cepa de bacillus subtilis como un componente activo. (divisional de solicitud n° 01463-2019)
BR112012006010A2 (pt) composto de glicina
BR112015011213A2 (pt) Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição.
BR112013007423A2 (pt) terapia combinada no que diz respeito ao tratamento da infecção por hcv
BR112012022074A2 (pt) composição compreendendo como ingredientes ativos l-carnitina em combinação com hidroxiquinurenina-o-beta-dl-glicosídeo, para a prevenção e/ou tratamento de patologias dos olhos devido à radiação ultravioleta
MX2015004009A (es) Regimen de glicosidasa para el tratatamiento de enfermedades infecciosas.
CO2019004004A2 (es) Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico
MX371329B (es) Factor de creciemiento similar a la insulina (igf) activo y su uso en infecciones por el virus del síndrome reproductivo y respiratorio porcino (prrsv).
AR087878A1 (es) Extractos de cynara scolymus para el tratamiento de la dislipidemia
BR112018000496A2 (pt) combinações farmacêuticas e seu uso
CL2018003270A1 (es) Una composición farmacéutica que comprende ácido carboxílico para tratar y prevenir congestión nasal.
BR112018067663A2 (pt) compostos derivados de sulfamato, processos para preparação dos mesmos e seus usos
EP3417869A4 (en) COMPOSITION CONTAINING RHIZOMA PHRAGMITIS EXTRACT AS AN ACTIVE INGREDIENT FOR PREVENTING, IMPROVING OR TREATING DISEASES AFFECTED BY ANTI-CANCER AGENT'S SECONDARY EFFECT
WO2016159584A3 (ko) 상지 또는 상백피 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
BR112017027082A2 (pt) composição farmacêutica, método para tratar infecção, extrato, método para reduzir a carga viral